Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Latest filing published 13 Mar 2026 for ANI Pharmaceuticals INC, €197k. Read the official filing
Filing timeline
BuySaleChristopher Mutz
Insider track record
Disclosed buys
0
Disclosed sells
11
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Christopher Mutz: trading record in brief
Christopher Mutz appears in our data through filings on ANI Pharmaceuticals Inc shares, published by SEC (Form 4). Between 15 February 2022 and 13 March 2026, the trades on record add up to 33 filings.
Every open-market trade on record is a sale: 11 sales worth €2.5M. The rest of the record consists of 22 share grants. Since January 2026: no purchases and 6 sales on the market.
The newest entry dates from 13 March 2026: an open-market sale of €197k, in ANI Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Christopher Mutz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations33 total
3,162 shares@ US$71.643.5% of flowCommon StockSEC:0001846487-26-000014:0
3,602 shares@ US$74.180.013% mcap5.7% of flowCommon StockSEC:0001846487-26-000012:2
3,314 shares@ US$74.040.012% mcap5.2% of flowCommon StockSEC:0001846487-26-000012:1
2,121 shares@ US$74.220.0076% mcap3.3% of flowCommon StockSEC:0001846487-26-000012:0
417 shares@ US$74.000.5% of flowCommon StockSEC:0001846487-26-000010:0
21,306 shares@ US$77.1524.8% of flowCommon StockSEC:0001846487-26-000008:0
5,323 shares@ US$78.020.020% mcap47.2% of flowCommon StockSEC:0001846487-26-000006:0
3,173 shares@ US$76.705.1% of flowCommon StockSEC:0001846487-26-000004:0
7,032 shares@ US$76.5511.2% of flowCommon StockSEC:0001846487-26-000004:1
2,403 shares@ US$77.363.9% of flowCommon StockSEC:0001846487-26-000004:2
4,546 shares@ US$76.255.2% of flowCommon StockSEC:0001846487-26-000002:0
4,000 shares@ US$60.455.3% of flowCommon StockSEC:0001846487-25-000008:0
2,874 shares@ US$60.624.0% of flowCommon StockSEC:0001846487-25-000006:0
1,275 shares@ US$61.891.9% of flowCommon StockSEC:0001846487-25-000004:0
1,473 shares@ US$58.922.0% of flowCommon StockSEC:0001846487-25-000002:2
1,184 shares@ US$58.921.6% of flowCommon StockSEC:0001846487-25-000002:3
24,808 shares0Common StockSEC:0001846487-25-000002:0
16,538 shares0Common StockSEC:0001846487-25-000002:1
6,500 shares@ US$57.708.8% of flowCommon StockSEC:0001846487-24-000014:0
2,000 shares@ US$61.612.8% of flowCommon StockSEC:0001846487-24-000012:0
2,110 shares@ US$66.713.2% of flowCommon StockSEC:0001846487-24-000010:0
5,000 shares@ US$66.007.5% of flowCommon StockSEC:0001846487-24-000008:0
1,275 shares@ US$67.672.0% of flowCommon StockSEC:0001846487-24-000006:0
1,261 shares@ US$57.551.7% of flowCommon StockSEC:0001846487-24-000004:0
18,790 shares0Common StockSEC:0001846487-24-000002:0
25 of 33 declarations
